{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T09:19:57Z","timestamp":1791883197793,"version":"4.3.4"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lungcancerjournal.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.lungcan.2023.107453","type":"journal-article","created":{"date-parts":[[2023,12,29]],"date-time":"2023-12-29T21:14:41Z","timestamp":1703884481000},"page":"107453","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Prognostic value of predominant subtype in pathological stage II\u2013III lung adenocarcinoma with epidermal growth factor receptor mutation"],"prefix":"10.1016","volume":"188","author":[{"given":"Shingo","family":"Kitagawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshitaka","family":"Zenke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuro","family":"Taki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiju","family":"Aokage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Shibata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Izumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaname","family":"Nosaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeki","family":"Umemura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shingo","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyotaka","family":"Yoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoya","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shingo","family":"Sakashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motohiro","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Tsuboi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Goto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-0828-5025","authenticated-orcid":false,"given":"Genichiro","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.lungcan.2023.107453_b0005","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1111\/cas.12275","article-title":"RET fusion gene: Translation to personalized lung cancer therapy","volume":"104","author":"Kohno","year":"2013","journal-title":"Cancer Sci."},{"issue":"18","key":"10.1016\/j.lungcan.2023.107453_b0010","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1056\/NEJMoa2027071","article-title":"Osimertinib in resected EGFR -mutated non\u2013small-cell lung cancer","volume":"383","author":"Wu","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.lungcan.2023.107453_b0015","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1200\/JCO.22.02186","article-title":"Adjuvant osimertinib for resected EGFR-mutated stage IB-IIIA non\u2013small-cell lung cancer: updated results from the phase III randomized ADAURA trial","volume":"41","author":"Herbst","year":"2023","journal-title":"JCO"},{"key":"10.1016\/j.lungcan.2023.107453_b0020","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.lungcan.2022.05.007","article-title":"Perioperative targeted therapy for oncogene-driven NSCLC","volume":"172","author":"Liu","year":"2022","journal-title":"Lung Cancer"},{"key":"10.1016\/j.lungcan.2023.107453_b0025","doi-asserted-by":"crossref","unstructured":"Isaka T, Ito H, Nakayama H, et al. Effect of epidermal growth factor receptor gene mutation on the prognosis of pathological stage II\u2013IIIA (8th edition TNM classification) primary lung cancer after curative surgery. Lung Cancer. 2021;162:128-134.","DOI":"10.1016\/j.lungcan.2021.11.002"},{"issue":"11","key":"10.1016\/j.lungcan.2023.107453_b0030","doi-asserted-by":"crossref","first-page":"e2131892","DOI":"10.1001\/jamanetworkopen.2021.31892","article-title":"Association of clinicopathologic and molecular tumor features with recurrence in resected early-stage epidermal growth factor receptor-positive non\u2013small cell lung cancer","volume":"4","author":"Saw","year":"2021","journal-title":"JAMA Netw. Open"},{"issue":"1","key":"10.1016\/j.lungcan.2023.107453_b0035","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.athoracsur.2020.05.041","article-title":"Clinical impacts of EGFR mutation status: analysis of 5780 surgically resected lung cancer cases","volume":"111","author":"Suda","year":"2021","journal-title":"Ann. Thorac. Surg."},{"issue":"3","key":"10.1016\/j.lungcan.2023.107453_b0040","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.jtcvs.2020.05.099","article-title":"Prognostic value of epidermal growth factor receptor gene mutation in resected lung adenocarcinoma","volume":"162","author":"Deng","year":"2021","journal-title":"J. Thorac. Cardiovasc. Surg."},{"issue":"1","key":"10.1016\/j.lungcan.2023.107453_b0045","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1186\/s12885-022-10057-w","article-title":"Prognostic factors for relapse-free survival in stage IB-IIIA primary lung adenocarcinoma by epidermal growth factor receptor mutation status","volume":"22","author":"Isaka","year":"2022","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.lungcan.2023.107453_b0050","doi-asserted-by":"crossref","first-page":"6450","DOI":"10.1038\/s41467-021-26806-7","article-title":"Genomic signatures define three subtype of EGFR-mutant stage II\u2013III non-small-cell lung cancer with distinct adjuvant therapy outcomes","volume":"12","author":"Liu","year":"2021","journal-title":"Nat. Commun."},{"issue":"Pt B","key":"10.1016\/j.lungcan.2023.107453_b0055","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.addr.2015.07.007","article-title":"Phenotypic and functional heterogeneity of cancer-associated fibroblast within the tumor microenvironment","volume":"99","author":"Ishii","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.lungcan.2023.107453_b0060","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/35094059","article-title":"Putting tumours in context","volume":"1","author":"Bissell","year":"2001","journal-title":"Nat. Rev. Cancer"},{"issue":"7203","key":"10.1016\/j.lungcan.2023.107453_b0065","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nature07205","article-title":"Cancer-related inflammation","volume":"454","author":"Mantovani","year":"2008","journal-title":"Nature"},{"issue":"45","key":"10.1016\/j.lungcan.2023.107453_b0070","doi-asserted-by":"crossref","first-page":"5904","DOI":"10.1038\/onc.2008.271","article-title":"The tumor microenvironment and its role in promoting tumor growth","volume":"27","author":"Whiteside","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.lungcan.2023.107453_b0075","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.lungcan.2022.08.007","article-title":"Immunogenomic profiling of lung adenocarcinoma reveals poorly differentiated tumors are associated with an immunogenic tumor microenvironment","volume":"172","author":"Akhave","year":"2022","journal-title":"Lung Cancer"},{"issue":"5","key":"10.1016\/j.lungcan.2023.107453_b0080","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.jtho.2022.02.005","article-title":"Clinicopathologic and genotypic features of lung adenocarcinoma characterized by the international association for the study of lung cancer grading system","volume":"17","author":"Fujikawa","year":"2022","journal-title":"J. Thorac. Oncol."},{"issue":"3","key":"10.1016\/j.lungcan.2023.107453_b0085","article-title":"Application of the novel grading system of invasive pulmonary adenocarcinoma in a real diagnostic scenario: a brief report of 9353 cases","volume":"4","author":"She","year":"2023","journal-title":"JTO Clin. Res. Rep."},{"issue":"10","key":"10.1016\/j.lungcan.2023.107453_b0090","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1016\/j.jtho.2020.06.001","article-title":"A grading system for invasive pulmonary adenocarcinoma: a proposal from the international association for the study of lung cancer pathology committee","volume":"15","author":"Moreira","year":"2020","journal-title":"J. Thorac. Oncol."},{"issue":"1","key":"10.1016\/j.lungcan.2023.107453_b0095","doi-asserted-by":"crossref","first-page":"16878","DOI":"10.1038\/s41598-017-17204-5","article-title":"QuPath: Open source software for digital pathology image analysis","volume":"7","author":"Bankhead","year":"2017","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.lungcan.2023.107453_b0100","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1002\/ijc.23611","article-title":"Podoplanin expression by cancer associated fibroblasts predicts poor prognosis of lung adenocarcinoma","volume":"123","author":"Kawase","year":"2008","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.lungcan.2023.107453_b0105","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1378\/chest.11-2458","article-title":"Prognostic impact of cancer-associated stromal cells in patients with stage I Lung adenocarcinoma","volume":"142","author":"Ito","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.lungcan.2023.107453_b0110","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.lungcan.2018.10.021","article-title":"Link between tumor-promoting fibrous microenvironment and an immunosuppressive microenvironment in stage I lung adenocarcinoma","volume":"126","author":"Sakai","year":"2018","journal-title":"Lung Cancer"},{"issue":"3","key":"10.1016\/j.lungcan.2023.107453_b0115","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/his.13390","article-title":"Podoplanin expression in cancer-associated fibroblasts predicts unfavourable prognosis in patients with pathological stage IA lung adenocarcinoma","volume":"72","author":"Kubouchi","year":"2018","journal-title":"Histopathology"},{"issue":"5","key":"10.1016\/j.lungcan.2023.107453_b0120","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.neo.2019.03.009","article-title":"Characterization of distinct populations of carcinoma-associated fibroblasts from non-small cell lung carcinoma reveals a role for ST8SIA2 in cancer cell invasion","volume":"21","author":"Hao","year":"2019","journal-title":"Neoplasia"},{"issue":"2","key":"10.1016\/j.lungcan.2023.107453_b0125","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s00428-019-02587-9","article-title":"Prognostic significance of combining immunohistochemical markers for cancer-associated fibroblasts in lung adenocarcinoma tissue","volume":"475","author":"Inoue","year":"2019","journal-title":"Virchows Arch."},{"issue":"10","key":"10.1016\/j.lungcan.2023.107453_b0130","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1097\/JTO.0b013e3181eba692","article-title":"Stromal macrophage expressing CD204 is associated with tumor aggressiveness in lung adenocarcinoma","volume":"5","author":"Ohtaki","year":"2010","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.lungcan.2023.107453_b0135","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.lungcan.2018.07.015","article-title":"The intratumoral distribution influences the prognostic impact of CD68- and CD204-positive macrophages in non-small cell lung cancer","volume":"123","author":"Li","year":"2018","journal-title":"Lung Cancer"},{"issue":"23","key":"10.1016\/j.lungcan.2023.107453_b0140","doi-asserted-by":"crossref","first-page":"34217","DOI":"10.18632\/oncotarget.9079","article-title":"Prognostic impact of tumor-associated macrophage infiltration in non-small cell lung cancer: A systemic review and meta-analysis","volume":"7","author":"Mei","year":"2016","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.lungcan.2023.107453_b0145","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.neo.2019.01.005","article-title":"Prognostic value of macrophage phenotypes in resectable non-small cell lung cancer assessed by multiplex immunohistochemistry","volume":"21","author":"Rakaee","year":"2019","journal-title":"Neoplasia"},{"issue":"16","key":"10.1016\/j.lungcan.2023.107453_b0150","doi-asserted-by":"crossref","first-page":"5220","DOI":"10.1158\/1078-0432.CCR-08-0133","article-title":"Prognostic effect of epithelial and stromal lymphocyte infiltration in non-small cell lung cancer","volume":"14","author":"Al-Shibli","year":"2008","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.lungcan.2023.107453_b0155","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/dju435","article-title":"Objective measurement and clinical significance of TILs in non-small cell lung cancer","volume":"107","author":"Schalper","year":"2015","journal-title":"JNCI: J. Natl. Cancer Inst."},{"issue":"11","key":"10.1016\/j.lungcan.2023.107453_b0160","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1093\/annonc\/mdw319","article-title":"Prognostic value of tumor-infiltrating lymphocytes differs depending on histological type and smoking habit in completely resected non-small-cell lung cancer","volume":"27","author":"Kinoshita","year":"2016","journal-title":"Ann. Oncol."},{"issue":"12","key":"10.1016\/j.lungcan.2023.107453_b0165","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1016\/j.jtho.2018.09.012","article-title":"Immune marker profiling and programmed death ligand 1 expression across NSCLC mutations","volume":"13","author":"Toki","year":"2018","journal-title":"J. Thorac. Oncol."}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500223009911?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500223009911?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T13:05:23Z","timestamp":1759237523000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500223009911"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":33,"alternative-id":["S0169500223009911"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2023.107453","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic value of predominant subtype in pathological stage II\u2013III lung adenocarcinoma with epidermal growth factor receptor mutation","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2023.107453","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107453"}}